Biostage Inc logo

Biostage Inc

$ 5.65 -0.35 (-5.83%) 11:32 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 65.63M
Enterprise V:
$ 65.12M
Volume:
1.40K
Avg Vol (2M):
2.82K
Also Trade In:
Volume:
1.40K
Market Cap $:
65.63M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.82K
Enterprise Value $:
65.12M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Biostage Inc is a biotechnology company which is developing engineered organ implants based on novel Cellframe technology. The Cellframe technology platform is being developed to treat life-threatening conditions of the esophagus, bronchus, and trachea. Its platform technology provides surgeons a new paradigm to address life-threatening conditions of the esophagus, bronchus, and trachea due to cancer, infection, trauma or congenital abnormalities.
Name Current Vs Industry Vs History
Cash-To-Debt 40.35
Equity-to-Asset 0.59
Debt-to-Equity 0.04
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 19.8
3-Year EPS without NRI Growth Rate 22.4
3-Year FCF Growth Rate 46.9
Name Current Vs Industry Vs History
5-Day RSI 34.83
9-Day RSI 43.26
14-Day RSI 47.32
6-1 Month Momentum % 15.03
12-1 Month Momentum % 70.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.25
Quick Ratio 2.25
Cash Ratio 2.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.8
Name Current Vs Industry Vs History
ROA % -344.45
ROIC % -1013.08
ROC (Joel Greenblatt) % -3984.15

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -6.3
EV-to-EBITDA -6.34
EV-to-FCF -26.36
Price-to-Net-Cash 28.57
Earnings Yield (Greenblatt) % -15.88

Financials

BSTG's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BSTG

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.95
Beta -1.5
Volatility % 87.26
14-Day RSI 47.32
14-Day ATR ($) 0.748183
20-Day SMA ($) 6.4025
12-1 Month Momentum % 70.8
52-Week Range ($) 1.98 - 9
Shares Outstanding (Mil) 11.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biostage Inc Filings

Document Form Filing Date
No Filing Data

Biostage Inc Analysis

Share your research

Headlines

See More
No news.